Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Symptoms of Schizophrenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00455234
What this trial is testing

Rapid Tranquillization Trial: TREC-India II

Who this might be right for
Psychotic DisordersAggression
Christian Medical College, Vellore, India 300
Not applicableNot Yet RecruitingNCT07791212
What this trial is testing

Dissecting Immunological and Autoimmune Mechanisms of Neuropsychiatric Diseases

Who this might be right for
Neuropsychiatric Symptom
King's College London 300
Large-scale testing (Phase 3)Study completedNCT00469365
What this trial is testing

Pharmacy Interventions to Improve Chronic Disease Medication Refill

Who this might be right for
DiabetesHypertensionHyperlipidemia+3 more
Medical University of South Carolina 3,048
Not applicableEnded earlyNCT02652832
What this trial is testing

Effects of Noninvasive Brain Stimulation Techniques on BDNF Levels

Who this might be right for
DepressionSchizophrenia
Hôpital le Vinatier 165
Not applicableStudy completedNCT01028677
What this trial is testing

Oxytocin Treatment of Schizophrenia

Who this might be right for
ParanoiaSchizophreniaSchizoaffective Disorder
University of North Carolina, Chapel Hill 17
Not applicableLooking for participantsNCT06278532
What this trial is testing

Validation of the Lithuanian Version of the BNSS, CDSS, and the SCoRS

Who this might be right for
SchizophreniaNegative Symptoms in SchizophreniaDepressive Symptoms Due to Primary Psychotic Disorder (Diagnosis)+1 more
Lithuanian University of Health Sciences 200
Large-scale testing (Phase 3)UnknownNCT02001103
What this trial is testing

Memantine add-on for Cognitive and Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
National Taiwan University Hospital 120
Large-scale testing (Phase 3)Study completedNCT00183443
What this trial is testing

Treatment of Mania Symptoms With Drug Therapy

Who this might be right for
Bipolar DisorderSchizophrenia
Palo Alto Veterans Institute for Research 75
Not applicableNot Yet RecruitingNCT07266376
What this trial is testing

Validation of a VOICE MAnagement Program in Schizophrenia VVoice MAPS

Who this might be right for
Mental DisorderSchizophrenia Diagnosis
Centre Hospitalier Universitaire de la Guadeloupe 116
Not applicableLooking for participantsNCT07509125
What this trial is testing

Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders

Who this might be right for
Alzheimer Dementia (AD)ALS - Amyotrophic Lateral SclerosisParkinson s Disease+7 more
Universitaire Ziekenhuizen KU Leuven 300
Not applicableStudy completedNCT00543088
What this trial is testing

Effectiveness of Anti-Psychotic in GPs Setting

Who this might be right for
SchizophreniaBipolar Disorder
AstraZeneca 250
Not applicableStudy completedNCT07364825
What this trial is testing

Acute Psychiatric Care at Home for Lower-risk Patients With Acute Psychiatric Illness Who Require Inpatient Care

Who this might be right for
PsychosisAnxietyDepression+1 more
Brigham and Women's Hospital 41
Testing effectiveness (Phase 2)Ended earlyNCT03929497
What this trial is testing

Flexible-dose Long-term Extension Study of Lu AF11167 in Patients With Schizophrenia With Prominent Negative Symptoms

Who this might be right for
Schizophrenia
H. Lundbeck A/S 96
Testing effectiveness (Phase 2)Study completedNCT03510741
What this trial is testing

Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder.

Who this might be right for
SchizophreniaSchizophreniform DisordersSchizoaffective Disorder
Pakistan Institute of Living and Learning 64
Testing effectiveness (Phase 2)Study completedNCT04521868
What this trial is testing

A 6-month Study to Evaluate Sulforaphane Effects in Schizophrenia Patients

Who this might be right for
Schizophrenia
Central South University 125
Post-approval studies (Phase 4)Study completedNCT02525991
What this trial is testing

Phase IV to Evaluate the Safety of Self-administered ADASUVE® in Agitated Patients Outside the Hospital Setting

Who this might be right for
Agitation
Ferrer Internacional S.A. 323
Early research (Phase 1)Study completedNCT02427542
What this trial is testing

Feasibility Trial of CBT for Depersonalisation in Psychosis

Who this might be right for
Psychotic DisordersDepersonalization
King's College London 20
Testing effectiveness (Phase 2)Study completedNCT00087542
What this trial is testing

Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug

Who this might be right for
HallucinationsPsychosesParkinson's Disease
ACADIA Pharmaceuticals Inc. 60
Not applicableStudy completedNCT00791440
What this trial is testing

Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
New York State Psychiatric Institute 34
Large-scale testing (Phase 3)Study completedNCT00640562
What this trial is testing

Quetiapine Extended Release Depression Symptoms

Who this might be right for
SchizophreniaDepression
AstraZeneca 216
Next Page